These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 30292011)
1. Umbilical Cord Blood Transplantation Using Reduced-Intensity Conditioning without Antithymocyte Globulin in Adult Patients with Severe Aplastic Anemia. Ochi T; Onishi Y; Nasu K; Onodera K; Kobayashi M; Ichikawa S; Fujiwara T; Fukuhara N; Yamada-Fujiwara M; Harigae H Biol Blood Marrow Transplant; 2019 Feb; 25(2):e55-e59. PubMed ID: 30292011 [TBL] [Abstract][Full Text] [Related]
2. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate. Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856 [TBL] [Abstract][Full Text] [Related]
3. [Reduced-intensity umbilical cord blood transplantation for adult patients with fulminant aplastic anemia]. Nishiwaki K; Sano K; Kamiyama Y; Hayashi K; Tanoue S; Katori M; Masuoka H; Aiba K Rinsho Ketsueki; 2018; 59(1):64-68. PubMed ID: 29415940 [TBL] [Abstract][Full Text] [Related]
4. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan. Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274 [TBL] [Abstract][Full Text] [Related]
5. Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation. Hiramoto N; Yamazaki H; Nakamura Y; Uchida N; Murata M; Kondo T; Yoshioka S; Eto T; Nishikawa A; Kimura T; Ichinohe T; Atsuta Y; Onishi Y; Suzuki R; Mori T; Ann Hematol; 2022 Jan; 101(1):165-175. PubMed ID: 34546409 [TBL] [Abstract][Full Text] [Related]
6. Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in China. Tong J; Xuan L; Sun Y; Huang D; Liu H; Zheng C; Zhu X; Tang B; Song K; Zhang X; Zhang L; Yao W; Lin D; Liu Q; Sun Z Biol Blood Marrow Transplant; 2017 Sep; 23(9):1541-1548. PubMed ID: 28499936 [TBL] [Abstract][Full Text] [Related]
7. A New Conditioning Regimen Can Significantly Promote Post-Transplant Immune Reconstitution and Improve the Outcome of Umbilical Cord Blood Transplantation for Patients. Yu ZP; Ding JH; Sun AN; Chen BA; Ge Z; Wu DP Stem Cells Dev; 2019 Oct; 28(20):1376-1383. PubMed ID: 31464164 [TBL] [Abstract][Full Text] [Related]
8. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience. Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558 [TBL] [Abstract][Full Text] [Related]
9. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation. Grosskreutz C; Ross V; Scigliano E; Fruchtman S; Isola L Biol Blood Marrow Transplant; 2003 Jul; 9(7):453-9. PubMed ID: 12869959 [TBL] [Abstract][Full Text] [Related]
10. [Single non-blood-related umbilical cord blood transplantation using a reduced-intensity conditioning regimen for the treatment of severe aplastic anemia]. Wu Y; Tang BL; Song KD; Sun GY; Pan TZ; Huang AJ; Yan BB; Zhu XY Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):68-73. PubMed ID: 38527841 [No Abstract] [Full Text] [Related]
11. An Antithymocyte Globulin-Free Conditioning Regimen Using Fludarabine and Cyclophosphamide Is Associated with Good Outcomes in Patients Undergoing Matched Related Family Donor Transplantation for Aplastic Anemia. George B; Lionel S; Selvarajan S; Abubacker FN; Korula A; Devasia AJ; Kulkarni U; Lakshmi KM; Sindhuvi E; Abraham A; Mathews V Transplant Cell Ther; 2021 May; 27(5):409.e1-409.e6. PubMed ID: 33965181 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic Matched Related Donor Bone Marrow Transplantation for Pediatric Patients With Severe Aplastic Anemia Using "Low-dose" Cyclophosphamide, ATG Plus Fludarabine. Takpradit C; Prockop SE; Kernan NA; Scaradavou A; Curran K; Ruggiero J; Zakak N; O'Reilly RJ; Boulad F J Pediatr Hematol Oncol; 2018 May; 40(4):e220-e224. PubMed ID: 29432302 [TBL] [Abstract][Full Text] [Related]
13. [Unrelated umbilical cord blood transplantation with TBI/Ara-c/CY non-ATG conditioning regimen for adults with hematologic malignancies]. Sun ZM; Liu HL; Geng LQ; Zhou CY; Wang XB; Ding KY; Tong J; Zhu WB; Liu X; Wang ZY Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(24):1660-4. PubMed ID: 22944153 [TBL] [Abstract][Full Text] [Related]
14. Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia. DeZern AE; Zahurak M; Symons H; Cooke K; Jones RJ; Brodsky RA Biol Blood Marrow Transplant; 2017 Mar; 23(3):498-504. PubMed ID: 28013015 [TBL] [Abstract][Full Text] [Related]
15. Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia. Ghanem KM; Kharfan-Dabaja MA; El-Solh H; Harris N; Kreidieh N; Nehme R; Muwakkit SA; Saab R; Bazarbachi A; Abboud MR Curr Res Transl Med; 2017 Sep; 65(3):115-119. PubMed ID: 28988743 [TBL] [Abstract][Full Text] [Related]
16. Umbilical Cord Blood Transplantation for Fanconi Anemia With a Special Focus on Late Complications: a Study on Behalf of Eurocord and SAAWP-EBMT. Rafii H; Volt F; Bierings M; Dalle JH; Ayas M; Rihani R; Faraci M; de Simone G; Sengeloev H; Passweg J; Cavazzana M; Costello R; Maertens J; Biffi A; Johansson JE; Montoro J; Guepin GR; Diaz MA; Sirvent A; Kenzey C; Rivera Franco MM; Cappelli B; Scigliuolo GM; Rocha V; Ruggeri A; Risitano A; De Latour RP; Gluckman E Transplant Cell Ther; 2024 May; 30(5):532.e1-532.e16. PubMed ID: 38452872 [TBL] [Abstract][Full Text] [Related]
17. Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies. Kang HJ; Hong KT; Lee JW; Kim H; Park KD; Shin HY; Lee SH; Yoo KH; Sung KW; Koo HH; Lee JW; Chung NG; Cho B; Kim HK; Koh KN; Im HJ; Seo JJ; Jung HJ; Park JE; Lee YH; Lim YT; Lim YJ; Kim SY; Yoo ES; Ryu KH; Lee JH; Park JA; Park SK; Ahn HS; Biol Blood Marrow Transplant; 2016 Aug; 22(8):1455-1459. PubMed ID: 27090956 [TBL] [Abstract][Full Text] [Related]
18. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study. Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS; Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256 [TBL] [Abstract][Full Text] [Related]
19. Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series. Hu M; Li J; Liu R; Zhang Z; Feng S; Zhong D; Tang R; Xuan L Ann Hematol; 2024 Jun; 103(6):2103-2111. PubMed ID: 38656370 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia. Onishi Y; Mori T; Yamazaki H; Hiramoto N; Zaimoku Y; Kanaya M; Matsue K; Onizuka M; Aotsuka N; Uchida N; Onodera K; Kanda J; Nakamae H; Yamamoto R; Kuriyama T; Kimura T; Ichinohe T; Atsuta Y; Transplant Cell Ther; 2023 Dec; 29(12):766.e1-766.e8. PubMed ID: 37730121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]